$709 Million is the total value of SABBY MANAGEMENT, LLC's 162 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 45.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | SPI ENERGY CO LTDput | $40,532,000 | -42.4% | 3,714 | -33.3% | 5.71% | -58.3% | |
Sell | ISHARES RUSSELL 2000put | $29,680,000 | -36.2% | 1,294 | -38.5% | 4.18% | -53.7% | |
Sell | SPDR S&P 500 ETF TRput | $18,578,000 | -43.8% | 434 | -48.0% | 2.62% | -59.3% | |
Sell | SPDR SERIES TRUSTput | $17,385,000 | -47.7% | 1,284 | -47.6% | 2.45% | -62.1% | |
Sell | KANDI TECHNOLOGIES GROUP INCput | $5,542,000 | -17.4% | 9,267 | -13.7% | 0.78% | -40.2% | |
Sell | CBAK ENERGY TECH INCput | $5,223,000 | -12.0% | 11,089 | -4.7% | 0.74% | -36.2% | |
NBEV | Sell | NEWAGE INC | $3,858,000 | -43.0% | 1,729,931 | -26.8% | 0.54% | -58.7% |
WIMI | Sell | WIMI HOLOGRAM CLOUD INCads | $3,437,000 | -46.9% | 626,095 | -36.2% | 0.48% | -61.5% |
ASXC | Sell | ASENSUS SURGICAL INC | $2,953,000 | -60.5% | 931,414 | -59.5% | 0.42% | -71.4% |
PCVX | Sell | VAXCYTE INC | $2,656,000 | -24.9% | 117,994 | -34.1% | 0.37% | -45.6% |
AUTL | Sell | AUTOLUS THERAPEUTICS LTDads | $2,656,000 | -11.8% | 400,050 | -23.8% | 0.37% | -36.2% |
ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $2,525,000 | -7.8% | 765,276 | -6.3% | 0.36% | -33.2% |
RDHL | Sell | REDHILL BIOPHARMA LTDads | $2,342,000 | -49.3% | 340,440 | -46.1% | 0.33% | -63.3% |
Sell | KEMPHARM INCcall | $2,224,000 | -42.4% | 1,735 | -58.6% | 0.31% | -58.2% | |
Sell | EKSO BIONICS HLDGS INC | $2,216,000 | -15.2% | 402,873 | -4.8% | 0.31% | -38.6% | |
CBLI | Sell | CLEVELAND BIOLABS INC | $2,188,000 | -13.0% | 400,080 | -16.5% | 0.31% | -37.0% |
MTC | Sell | MMTEC INC | $2,087,000 | -39.6% | 1,003,477 | -25.7% | 0.29% | -56.3% |
NUZE | Sell | NUZEE INC | $2,079,000 | -38.3% | 660,044 | -31.6% | 0.29% | -55.3% |
Sell | 9 METERS BIOPHARMA INCput | $1,994,000 | -34.9% | 18,128 | -30.8% | 0.28% | -52.9% | |
Sell | ORAMED PHARMACEUTICALS INCput | $1,897,000 | +10.7% | 1,418 | -15.9% | 0.27% | -19.8% | |
Sell | ASENSUS SURGICAL INCput | $1,773,000 | -21.6% | 5,594 | -19.6% | 0.25% | -43.2% | |
AFIB | Sell | ACUTUS MEDICAL INC | $1,751,000 | -1.2% | 103,100 | -22.2% | 0.25% | -28.4% |
Sell | XPRESSPA GROUP INCput | $1,706,000 | -28.5% | 11,077 | -14.6% | 0.24% | -48.1% | |
Sell | CALADRIUS BIOSCIENCES INCput | $1,677,000 | -27.3% | 10,414 | -12.9% | 0.24% | -47.4% | |
Sell | ADITX THERAPEUTICS INCput | $1,402,000 | +1.4% | 5,414 | -0.2% | 0.20% | -26.4% | |
Sell | TRILLIUM THERAPEUTICS INC | $1,392,000 | -35.0% | 143,496 | -28.1% | 0.20% | -53.0% | |
INFI | Sell | INFINITY PHARMACEUTICALS | $1,320,000 | -22.9% | 441,473 | -16.7% | 0.19% | -44.1% |
DXR | Sell | DAXOR CORP | $1,033,000 | -28.1% | 97,487 | -17.9% | 0.15% | -47.9% |
MRTX | Sell | MIRATI THERAPEUTICS INC | $969,000 | -33.4% | 6,000 | -29.4% | 0.14% | -51.6% |
BPTS | Sell | BIOPHYTIS SAads | $964,000 | -18.4% | 91,018 | -1.4% | 0.14% | -40.9% |
EYES | Sell | SECOND SIGHT MEDICAL PRODS INC | $864,000 | -88.6% | 174,900 | -81.0% | 0.12% | -91.8% |
TXMD | Sell | THERAPEUTICSMD INC | $744,000 | -30.6% | 625,000 | -21.9% | 0.10% | -49.8% |
SHIP | Sell | SEANERGY MARITIME HLDGS CORP | $728,000 | -65.6% | 650,000 | -67.4% | 0.10% | -74.9% |
VRPX | Sell | VIRPAX PHARMACEUTICALS INC | $704,000 | -25.3% | 154,737 | -22.6% | 0.10% | -45.9% |
Sell | APPLIED GENETIC TECHNOLOGIESput | $604,000 | -68.4% | 1,545 | -59.1% | 0.08% | -77.2% | |
DGLY | Sell | DIGITAL ALLY INC NEW | $598,000 | -47.0% | 332,375 | -52.0% | 0.08% | -61.8% |
AMPGW | Sell | AMPLITECH GROUP INC*w | $554,000 | -63.1% | 337,599 | -1.4% | 0.08% | -73.3% |
Sell | DIGINEX LTDput | $320,000 | -50.7% | 488 | -17.6% | 0.04% | -64.3% | |
SLRX | Sell | SALARIUS PHARMACEUTICALS | $264,000 | -33.2% | 249,033 | -6.7% | 0.04% | -51.9% |
Sell | MACROGENICS INCcall | $247,000 | -73.1% | 92 | -68.1% | 0.04% | -80.3% | |
UK | Sell | UCOMMUNE INTL LTD | $223,000 | -42.2% | 100,650 | -21.7% | 0.03% | -58.7% |
AEZS | Sell | AETERNA ZENTARIS INC | $214,000 | -68.6% | 244,240 | -59.2% | 0.03% | -77.4% |
Sell | PLURISTEM THERAPEUTICS INCput | $210,000 | -74.7% | 531 | -69.5% | 0.03% | -81.5% | |
LIXT | Sell | LIXTE BIOTECHNOLOGY INC | $199,000 | -24.0% | 65,511 | -17.8% | 0.03% | -45.1% |
Sell | HEPION PHARMS INCput | $194,000 | -23.6% | 980 | -29.1% | 0.03% | -44.9% | |
Sell | VASCULAR BIOGENICS LTDput | $117,000 | -29.1% | 492 | -40.4% | 0.02% | -50.0% | |
Sell | CARDIFF ONCOLOGY INCput | $111,000 | -28.8% | 167 | -1.2% | 0.02% | -46.7% | |
Sell | TRILLIUM THERAPEUTICS INCcall | $117,000 | -83.1% | 121 | -81.3% | 0.02% | -88.1% | |
LIXTW | Sell | LIXTE BIOTECHNOLOGY INC*w | $107,000 | -16.4% | 140,089 | -11.0% | 0.02% | -40.0% |
Sell | AETERNA ZENTARIS INCput | $81,000 | -64.3% | 920 | -53.9% | 0.01% | -75.0% | |
Sell | NABRIVA THERAPEUTICS PLC | $78,000 | -71.3% | 57,766 | -64.8% | 0.01% | -79.2% | |
BKYI | Sell | BIO-KEY INTL INC | $65,000 | -44.4% | 16,995 | -49.2% | 0.01% | -60.9% |
Sell | IT TECH PACKAGINGput | $58,000 | -67.2% | 1,228 | -54.2% | 0.01% | -76.5% | |
ODT | Sell | ODONATE THERAPEUTICS INC | $52,000 | -97.6% | 14,979 | -97.6% | 0.01% | -98.3% |
CJJD | Exit | CHINA JO JO DRUGSTORES INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
Exit | AETERNA ZENTARIS INCcall | $0 | – | -462 | -100.0% | -0.01% | – | |
PHAS | Exit | PHASEBIO PHARMACEUTICALS INC | $0 | – | -15,000 | -100.0% | -0.01% | – |
Exit | DIGITAL ALLY INCcall | $0 | – | -309 | -100.0% | -0.01% | – | |
AVEO | Exit | AVEO PHARMACEUTICALS INC | $0 | – | -10,815 | -100.0% | -0.02% | – |
Exit | ACTINIUM PHARMACEUTICALS INCput | $0 | – | -100 | -100.0% | -0.02% | – | |
Exit | POLARITYTE INCput | $0 | – | -1,355 | -100.0% | -0.03% | – | |
RVPHW | Exit | REVIVA PHARMACEURICALS HLDGS INC*w | $0 | – | -350,000 | -100.0% | -0.03% | – |
NTEC | Exit | INTEC PHARMA LTD | $0 | – | -37,501 | -100.0% | -0.03% | – |
RKDA | Exit | ARCADIA BIOSCIENCES INC | $0 | – | -67,136 | -100.0% | -0.04% | – |
CLGN | Exit | COLLPLANT BIOTECHNOLOGIES LTDads | $0 | – | -17,045 | -100.0% | -0.04% | – |
PTE | Exit | POLARITYTE INC | $0 | – | -210,562 | -100.0% | -0.05% | – |
PSTI | Exit | PLURISTEM THERAPEUTICS INC | $0 | – | -50,822 | -100.0% | -0.05% | – |
Exit | CARDIFF ONCOLOGY INCcall | $0 | – | -275 | -100.0% | -0.05% | – | |
AGFY | Exit | AGRIFY CORP | $0 | – | -21,342 | -100.0% | -0.05% | – |
Exit | ADAMIS PHARMACEUTICALS CORPput | $0 | – | -3,034 | -100.0% | -0.06% | – | |
Exit | AVEO PHARMACEUTICALS INCput | $0 | – | -620 | -100.0% | -0.09% | – | |
MITO | Exit | STEALTH BIOTHERAPEUTICS CORPads | $0 | – | -301,575 | -100.0% | -0.09% | – |
BPTH | Exit | BIO PATH HLDGS INC | $0 | – | -71,920 | -100.0% | -0.10% | – |
IWM | Exit | ISHARES RUSSELL 2000etf | $0 | – | -2,372 | -100.0% | -0.10% | – |
BFLY | Exit | BUTTERFLY NETWORK INC | $0 | – | -33,047 | -100.0% | -0.11% | – |
CTXR | Exit | CITIUS PHARMACEUTICALS INC | $0 | – | -314,000 | -100.0% | -0.11% | – |
HEPA | Exit | HEPION PHARMACEUTICALS INC | $0 | – | -306,338 | -100.0% | -0.11% | – |
NMTR | Exit | 9 METERS BIOPHARMA INC | $0 | – | -564,527 | -100.0% | -0.13% | – |
HMCOU | Exit | HUMANCO ACQUISITION CORPunit | $0 | – | -67,974 | -100.0% | -0.14% | – |
Exit | CURIS INCcall | $0 | – | -985 | -100.0% | -0.18% | – | |
CLBS | Exit | CALADRIUS BIOSCIENCES INC | $0 | – | -484,970 | -100.0% | -0.18% | – |
Exit | SPI ENERGY CO LTD | $0 | – | -131,898 | -100.0% | -0.19% | – | |
AUPH | Exit | AURINIA PHARMACEUTICALS | $0 | – | -85,625 | -100.0% | -0.22% | – |
XBI | Exit | SPDR SERIES TRUSTetf | $0 | – | -8,735 | -100.0% | -0.23% | – |
Exit | SAGE THERAPEUTICS INCput | $0 | – | -166 | -100.0% | -0.24% | – | |
Exit | ARKput | $0 | – | -114 | -100.0% | -0.27% | – | |
XELA | Exit | EXELA TECHNOLOGIES | $0 | – | -750,000 | -100.0% | -0.32% | – |
Exit | IONIS PHARMACEUTICALScall | $0 | – | -428 | -100.0% | -0.37% | – | |
Exit | ASENSUS SURGICAL INCcall | $0 | – | -6,556 | -100.0% | -0.42% | – | |
RVPH | Exit | REVIVA PHARMACEURICALS HLDGS INC | $0 | – | -418,437 | -100.0% | -0.47% | – |
Exit | CEL-SCI CORPcall | $0 | – | -1,760 | -100.0% | -0.52% | – | |
Exit | BIOGEN INCput | $0 | – | -100 | -100.0% | -0.54% | – | |
VTSI | Exit | VIRTRA INC | $0 | – | -561,088 | -100.0% | -0.67% | – |
PENN | Exit | PENN NATIONAL GAMING INC | $0 | – | -40,399 | -100.0% | -0.82% | – |
VXX | Exit | BARCLAYS BANK PLCetf | $0 | – | -525,000 | -100.0% | -1.16% | – |
Exit | PENN NATIONAL GAMING INCput | $0 | – | -731 | -100.0% | -1.49% | – | |
Exit | SPDR GOLD TRUSTcall | $0 | – | -966 | -100.0% | -3.01% | – | |
Exit | BARCLAYS BANK PLCcall | $0 | – | -14,336 | -100.0% | -3.18% | – | |
Exit | BIOGEN INCcall | $0 | – | -1,518 | -100.0% | -8.26% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.